Background {#Sec1}
==========

Perinatal depression, a mental illness that occurs either during pregnancy or within the first 12 months after delivery, affects the health and development of mothers and children \[[@CR1], [@CR2]\]. In 1968, Pitt reported that the prevalence of postpartum depression was 11% \[[@CR3]\]. Epidemiological investigations have been conducted worldwide since then. In 1987, Cox developed the Edinburgh Postnatal Depression Scale (EPDS) \[[@CR4]\], and screening measures have since progressed rapidly. In 1996, in the first meta-analysis of postpartum depression, the prevalence of postpartum depression was reported to be 13% \[[@CR5]\]. Recently, estimates of the prevalence of postpartum depression in Western countries have reportedly been in the range of 13--19% \[[@CR6]\].

Postpartum depression has been reported to occur due to biological \[[@CR7]\], psychological and social problems. Social support from family members has a strong impact on postpartum depression \[[@CR5]\]. Since the establishment of an equal employment policy for women in 1985, the employment rate of women has rapidly increased in Japan. However, there is insufficient social infrastructure for childcare, such as daycare, and men are not very involved in parenting. In addition, with the aging population and the increasing prevalence of nuclear families, social support in the perinatal period tends to be insufficient. In particular, the aging rate is 27.3% \[[@CR8]\], which is the highest rate among developed countries, and support from family members, such as maternal parents, is weakening. For this reason, mental stress in women during the perinatal period is strong, and the risk of developing depression may be high. Therefore, it is problematic to apply current epidemiology data from different countries and regions to the Japanese context because of the social differences. Previous reports have suggested that perinatal depression may be affected by differences in economic status, social support, or ethnicity in the country where patients live \[[@CR2], [@CR5]\]. For this reason, we thought it would be relevant to conduct research focused on the country and culture of Japan.

In recent years, a large, prospective nationwide cohort study (*n* = 82,489) called the "Japan Environment and Children's Study" (JECS) showed a 13.7% prevalence of postpartum depression among women 1 month after childbirth \[[@CR9]\]. Although other studies on postpartum depression with various sample sizes have been carried out in Japan, with most of them written in Japanese, meta-analyses have not been conducted. For this reason, we collected articles for this study including those written in Japanese. The aim of our meta-analysis was to calculate a reliable estimate of the prevalence of postpartum depression among Japanese women. In addition, some studies have reported that the birth experience influences postpartum depression \[[@CR9], [@CR10]\], while other studies have indicated that there is no relation between the childbirth experience and postpartum depression \[[@CR11], [@CR12]\]. Therefore, we undertook a subanalysis of the relationship between postpartum depression and the childbirth experience.

Method {#Sec2}
======

Study selection {#Sec3}
---------------

This systematic review was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standards (a protocol used to evaluate systematic reviews) \[[@CR13]\]. We searched for published studies related to perinatal depression in the PubMed electronic database. The search phrase was ((pregnancy \[ALL\] OR antenatal \[ALL\] OR prenatal \[ALL\] OR gestation \[ALL\] OR postnatal \[ALL\] OR postpartum \[ALL\] OR postpartal \[ALL\] OR perinatal \[ALL\] OR puerperium \[ALL\] OR puerperal \[ALL\] OR postbirth \[ALL\] OR post-birth \[ALL\]) AND (depression \[ALL\] OR depressive \[ALL\] OR mood disorder \[ALL\] OR affective disorder \[ALL\]) AND (Japan \[ALL\] OR Japanese \[ALL\])).

In addition, the ICHUSHI database (<http://search.jamas.or.jp/>) was searched for articles written in Japanese. ICHUSHI contains bibliographic citations and abstracts from biomedical journals and other serial publications published in Japan. We used comparable Japanese search terms without the terms "Japan" and "Japanese" to search ICHUSHI.

The two electronic databases, PubMed and ICHUSHI, were searched for studies published from January 1, 1994, to December 31, 2017. We excluded older literature before the release of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) \[[@CR14]\]. Then, we examined the list of references included in the articles.

Inclusion and exclusion criteria {#Sec4}
--------------------------------

Studies were eligible for inclusion if they (a) included women who were 16 years or older; (b) assessed prenatal or postpartum depression using a validated self-report instrument; (c) reported the results of peer-reviewed research based on cross-sectional or prospective studies; and (d) reported data to estimate the prevalence of prenatal or postpartum depression using the EPDS or Center for Epidemiologic Studies Depression Scale (CES-D). Studies were excluded if they (a) recruited only high-risk women; (b) reported results for only a subsample of a study population; (c) reported duplicate data from a single database; (d) reported only mean data; (e) did not report a cutoff point for depression; or (f) had \< 100 participants (these studies were excluded to avoid a small-study effect) \[[@CR15]\]. For studies with duplicate data from a single database, we selected the study with the larger sample size. Case reports, comments, editorials, letters, and studies not performed on human participants were also excluded. Two researchers (KT and NS) independently searched the literature. After all papers had been assessed, any discrepancies in the responses were identified and discussed to reach a consensus on the best option. Disagreements about the inclusion of a study were resolved through discussion with the senior author (NYF). Data were extracted from each article using a standardized form including the first author, publication year and other information.

Data extraction {#Sec5}
---------------

From each study, we extracted information about the publication year, sample size, measures used to assess depression, cutoff point used for each measure, time points for depression assessment, and percent of the prevalence of prenatal or postpartum depression. Publication year, parity, and perinatal depression prevalence were used as continuous variables.

The time of measurement was defined as the first trimester (i.e., 0 to 3 months gestation; Time 1 \[T1\]), second trimester (i.e., \> 3 to 6 months gestation; Time 2 \[T2\]), third trimester (i.e., \> 6 months gestation to childbirth; Time 3 \[T3\]), 0 to 1 month postpartum (Time 4 \[T4\]), \> 1 to 3 months postpartum (Time 5 \[T5\]), \> 3 to 6 months postpartum (Time 6 \[T6\]), and \> 6 months to 1 year postpartum (Time 7 \[T7\]). Data from the checkup 1 month after childbirth were extracted separately.

Moreover, for intervention studies, only the baseline data were extracted. For longitudinal studies, only data on the rate of depression from one time point in each period (e.g., prenatal and postpartum) were included in the analyses. For most studies, the first time point was used, as the participants were least familiar with the study tool at that point and were unlikely to exhibit priming effects.

We collected papers that evaluated postpartum depression using the Japanese versions of the EPDS and CES-D.

The EPDS is a self-report instrument measuring postnatal depression with 10 items rated on a 4-point scale (from 0 to 3). The total score ranges from 0 to 30; the higher the score, the worse the symptoms of depression are. The reliability and validity of the Japanese version of the EPDS were reported by Okano, and a cutoff point above 9 was established \[[@CR16]\]. Our meta-analysis also included a paper that evaluated depression by using the Japanese version \[[@CR17]\] of the CES-D \[[@CR18]\]. This tool consists of 20 questions about depression, and the total score ranges from 0 to 60 points. We collected papers that defined the presence of depression based on a CES-D score ≥ 16.

Statistical analysis {#Sec6}
--------------------

First, we assessed the pooled prevalence of postpartum depression at the time of the checkup 1 month after childbirth. Then, we assessed the pooled prevalence of perinatal or postpartum depression during each period (T1 to T7). Third, we conducted a trend analysis applied the generalized linear mixed model \[[@CR19]\]. The *t* tests on the contrast vectors for regression coefficients of the time variable were conducted in order to evaluate the difference between time points in the prenatal period, and the trend of proportion in the post period. Finally, we calculated the relative risk to investigate the differences in the prevalence of postpartum depression between primiparas and multiparas.

We used the *I*^2^ statistic and its 95% CI to estimate heterogeneity. The *I*^2^ statistic was considered high when it was 75% or higher \[[@CR20]\]. The significance level was set at *p* \< 0.05. The meta-analysis and related statistical analysis were performed with meta-package version 4.9-1 in R version 3.5.0., and the GLIMMIX procedure in SAS ver. 9.4.

Results {#Sec7}
=======

Search results and included participants {#Sec8}
----------------------------------------

After excluding duplicate or irrelevant papers, we found 123 publications that met the inclusion criteria (Fig. [1](#Fig1){ref-type="fig"}). The final sample included 108,431 people assessed at the time of the checkup 1 month after childbirth. The sample sizes of the studies ranged from 100 to 82,489 people. More details on the included studies and participants are presented Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}.Fig. 1Flowchart of the process of selecting studies for inclusionTable 1Major characteristics of studies: the prevalence of prenatal and postpartum depressionAuthor, yearTime classificationMeasureSample sizeIdentified casesPrevalence (%)Akiyama 2014 \[[@CR45]\]1- to 3-month postpartumEPDS93632434.6Amagai 2014 \[[@CR46]\]Third trimesterEPDS1513321.9Arai 2009 \[[@CR47]\]1-month postpartumEPDS1493322.10- to 1-month postpartumEPDS1493322.1Arakawa 2016 \[[@CR48]\]1-month postpartumEPDS257238.90- to 1-month postpartumEPDS2533614.21- to 3-month postpartumEPDS289269.0Arimoto 2010 \[[@CR49]\]1-month postpartumEPDS2766623.90- to 1-month postpartumEPDS2766623.9Doi 2015 \[[@CR50]\]0- to 1-month postpartumEPDS1002020.0Ebine 2007 \[[@CR51]\]1-month postpartumEPDS69113119.00- to 1-month postpartumEPDS69113119.0Emori 2014 \[[@CR52]\]Third trimesterEPDS1102018.2Fujita 2007 \[[@CR54]\]1-month postpartumEPDS186922211.90- to 1-month postpartumEPDS186922211.9Fujita 2015 \[[@CR53]\]1-month postpartumEPDS1793821.20- to 1-month postpartumEPDS1793821.2Fukuda 2011 \[[@CR55]\]1-month postpartumEPDS2995719.10- to 1-month postpartumEPDS2995719.1Fukuzawa 2003 \[[@CR56]\]0- to 1-month postpartumEPDS1942512.91- to 3-month postpartumEPDS194105.2Fukuzawa 2004 \[[@CR57]\]1-month postpartumEPDS664314.70- to 1-month postpartumEPDS6647210.8Fukuzawa 2006 \[[@CR58]\]1-month postpartumEPDS356174.80- to 1-month postpartumEPDS356329.0Fukuzawa 2011 \[[@CR59]\]1-month postpartumEPDS13585.90- to 1-month postpartumEPDS135139.61- to 3-month postpartumEPDS135118.13- to 6-month postpartumEPDS135139.66- to 12-month postpartumEPDS135139.6Goto 2010 \[[@CR60]\]3- to 6-month postpartumEPDS378328.5Hamazaki 2009 \[[@CR61]\]1-month postpartumEPDS986919.20- to 1-month postpartumEPDS986919.2Harada 2008 \[[@CR62]\]1-month postpartumEPDS820688.30- to 1-month postpartumEPDS820688.3Harada 2009 \[[@CR63]\]1-month postpartumEPDS1431812.60- to 1-month postpartumEPDS1432014.03- to 6-month postpartumEPDS143128.4Hashimoto 2014 \[[@CR64]\]1- to 3-month postpartumEPDS12221028.3Honda 2008 \[[@CR65]\]1-month postpartumEPDS2303113.50- to 1-month postpartumEPDS2303113.5Hori 2006 \[[@CR66]\]1- to 3-month postpartumEPDS2172913.4Hosoya 2006 \[[@CR67]\]1-month postpartumEPDS2043316.20- to 1-month postpartumEPDS2043316.2Hozumi 2005 \[[@CR68]\]0- to 1-month postpartumEPDS1101614.5Ichikawa 2008 \[[@CR69]\]1-month postpartumEPDS1522919.10- to 1-month postpartumEPDS1522919.1Imura 2004 \[[@CR70]\]0- to 1-month postpartumEPDS1022120.6Ishii 2010 \[[@CR71]\]1-month postpartumEPDS10943.70- to 1-month postpartumEPDS10965.5Ishikawa 2011 \[[@CR72]\]Third trimesterEPDS4244811.3Iwafuji 2007 \[[@CR73]\]3- to 6-month postpartumCES-D1291310.16- to 12-month postpartumCES-D1292015.5Iwamoto 2010 \[[@CR74]\]1-month postpartumEPDS590305.10- to 1-month postpartumEPDS5906511.03- to 6-month postpartumEPDS560417.3Third trimesterEPDS59010117.1Iwata 2016 \[[@CR75]\]0- to 1-month postpartumEPDS285443715.3Iwata 2016 \[[@CR76]\]1- to 3-month postpartumEPDS27092619.63- to 6-month postpartumEPDS27092228.2Kanai 2016 \[[@CR77]\]1-month postpartumEPDS11387.10- to 1-month postpartumEPDS11387.1Kanazawa 2008 \[[@CR78]\]1-month postpartumEPDS1111614.40- to 1-month postpartumEPDS1111614.4Kaneko 2008 \[[@CR79]\]1-month postpartumEPDS1031514.60- to 1-month postpartumEPDS1031514.6Second trimesterEPDS1031312.6Kawai 2017 \[[@CR80]\]0- to 1-month postpartumEPDS95111512.11- to 3-month postpartumEPDS951474.96- to 12-month postpartumEPDS951404.2Kawamura 2006 \[[@CR81]\]0- to 1-month postpartumEPDS50610019.83- to 6-month postpartumEPDS22832269.9Kikuchi 2010 \[[@CR83]\]1-month postpartumEPDS1131715.00- to 1-month postpartumEPDS1131715.03- to 6-month postpartumEPDS1131715.0Kinjo 2011 \[[@CR84]\]1-month postpartumEPDS1523925.70- to 1-month postpartumEPDS1523925.7Kinjo 2013 \[[@CR85]\]1- to 3-month postpartumCES-D2899633.2Second trimesterCES-D32010031.3Kishi 2009 \[[@CR86]\]1-month postpartumEPDS1602012.50- to 1-month postpartumEPDS1602012.5Kobayashi 2017 \[[@CR10]\]1-month postpartumEPDS96719119.80- to 1-month postpartumEPDS96719119.83- to 6-month postpartumEPDS7109112.8Kondo 2011 \[[@CR88]\]1- to 3-month postpartumEPDS1291410.9Kubota 2014 \[[@CR89]\]1-month postpartumEPDS69012718.40- to 1-month postpartumEPDS69012718.4Maruyama 2012 \[[@CR106]\]1-month postpartumEPDS1433625.20- to 1-month postpartumEPDS1433625.2Masuda 2012 \[[@CR90]\]1-month postpartumEPDS5958915.00- to 1-month postpartumEPDS5958915.0Matsukida 2009 \[[@CR91]\]0- to 1-month postpartumEPDS12401028.2Matsuoka 2010 \[[@CR93]\]1- to 3-month postpartumEPDS5086913.6Matsuzaki 2009 \[[@CR94]\]1-month postpartumEPDS443409.00- to 1-month postpartumEPDS436378.51- to 3-month postpartumEPDS154138.4Mishina 2009 \[[@CR95]\]1-month postpartumEPDS1031716.50- to 1-month postpartumEPDS1031716.5Mishina 2010 \[[@CR96]\]1-month postpartumEPDS2794315.40- to 1-month postpartumEPDS2794315.4Mishina 2012 \[[@CR97]\]0- to 1-month postpartumEPDS6318713.81- to 3-month postpartumEPDS162118211.23- to 6-month postpartumEPDS3124113.1Mitamura 2008 \[[@CR98]\]1-month postpartumEPDS503408.00- to 1-month postpartumEPDS503408.0Miyake 2011\[[@CR100]\]3- to 6-month postpartumEPDS77110613.7Miyake 2016 \[[@CR99]\]3- to 6-month postpartumCES-D13191088.2Miyauchi 2014 \[[@CR102]\]1- to 3-month postpartumEPDS410317.6Mori 2017 \[[@CR104]\]1-month postpartumEPDS285443715.3Morikawa 2015 \[[@CR105]\]Second trimesterEPDS3716818.3Muchanga 2017 \[[@CR9]\]1-month postpartumEPDS82,48911,34113.70- to 1-month postpartumEPDS82,48911,34113.7Murayama 2010 \[[@CR107]\]1- to 3-month postpartumEPDS2302310.0Nagatsuru 2006 \[[@CR108]\]1-month postpartumEPDS2526224.60- to 1-month postpartumEPDS2526224.6Nakaita 2012 \[[@CR109]\]1-month postpartumEPDS174423313.40- to 1-month postpartumEPDS174423313.43- to 6-month postpartumEPDS236428612.1Nakamura 2015 \[[@CR12]\]1-month postpartumEPDS215198.80- to 1-month postpartumEPDS215198.8Nakano 2004 \[[@CR110]\]0- to 1-month postpartumEPDS1692917.2Ngoma 2012 \[[@CR111]\]1-month postpartumEPDS11776.00- to 1-month postpartumEPDS11776.0Nishigori 2015 \[[@CR113]\]0- to 1-month postpartumEPDS3004515.0Nishihira 2011 \[[@CR114]\]1-month postpartumEPDS1792413.40- to 1-month postpartumEPDS1792413.41- to 3-month postpartumEPDS1001313.0Nishikawa 2006 \[[@CR115]\]0- to 1-month postpartumEPDS2483714.91-month postpartumEPDS2483714.9Nishimura 2010 \[[@CR117]\]1-month postpartumEPDS1785028.10- to 1-month postpartumEPDS1785028.1Nishimura 2015 \[[@CR116]\]3- to 6-month postpartumEPDS8078310.3Nishioka 2011 \[[@CR118]\]1-month postpartumEPDS4057919.50- to 1-month postpartumEPDS4057919.53- to 6-month postpartumEPDS653538.1Nishizono-Maher 2004 \[[@CR119]\]3- to 6-month postpartumEPDS6939613.9Ogasawara 2000 \[[@CR120]\]1-month postpartumEPDS16174.30- to 1-month postpartumEPDS16174.3Ono 2008 \[[@CR122]\]1-month postpartumEPDS1513321.90- to 1-month postpartumEPDS1513321.9Ono 2009 \[[@CR122]\]3- to 6-month postpartumEPDS4859920.4Otake 2014 \[[@CR123]\]Third trimesterEPDS15495.8Sadatomi 2011 \[[@CR124]\]1-month postpartumEPDS201199.50- to 1-month postpartumEPDS201199.5Sakae 2016 \[[@CR125]\]1-month postpartumEPDS1102522.70- to 1-month postpartumEPDS1101614.51- to 3-month postpartumEPDS1101715.53- to 6-month postpartumEPDS1101513.66- to 12-month postpartumEPDS1101816.4Third trimesterEPDS1101917.3Sasaki 2007 \[[@CR127]\]0- to 1-month postpartumEPDS3144113.1Sasaki 2012 \[[@CR126]\]1-month postpartumEPDS3144915.60- to 1-month postpartumEPDS3144915.6Sato 2002 \[[@CR130]\]1-month postpartumEPDS4025914.70- to 1-month postpartumEPDS4028420.9Sato 2006 \[[@CR128]\]1-month postpartumEPDS1893216.90- to 1-month postpartumEPDS1893719.61- to 3-month postpartumEPDS1892714.30- to 1-month postpartumEPDS1031312.6Sato 2016 \[[@CR129]\]6- to 12-month postpartumEPDS67714521.4Satoh 2009 \[[@CR131]\]3- to 6-month postpartumEPDS1774223.7Seki 2015 \[[@CR132]\]1- to 3-month postpartumEPDS3367121.1Shin 2015 \[[@CR133]\]1- to 3-month postpartumEPDS1671810.8Shiraishi 2015 \[[@CR134]\]Second trimesterEPDS329195.8Shoji 2009 \[[@CR135]\]1-month postpartumEPDS14774.80- to 1-month postpartumEPDS147149.5Suetsugu 2015 \[[@CR136]\]1-month postpartumEPDS244197.80- to 1-month postpartumEPDS244197.8Sugimoto 2017 \[[@CR137]\]3- to 6-month postpartumEPDS213326212.3Sugishita 2013 \[[@CR138]\]1-month postpartumEPDS1212419.80- to 1-month postpartumEPDS1212419.8Suzuki 2001 \[[@CR139]\]1-month postpartumEPDS186427514.80- to 1-month postpartumEPDS186427514.8Suzuki 2010 \[[@CR140]\]0- to 1-month postpartumEPDS684385.6Suzumiya 2004 \[[@CR141]\]0- to 1-month postpartumEPDS78015019.21- to 3-month postpartumEPDS233429612.73- to 6-month postpartumEPDS256239.0Tachibana 2015 \[[@CR142]\]1-month postpartumEPDS132716912.70- to 1-month postpartumEPDS132716912.7Second trimesterEPDS13271289.6Takahashi 2014 \[[@CR143]\]1-month postpartumEPDS1001010.00- to 1-month postpartumEPDS1001010.0Takehara 2009 \[[@CR144]\]3- to 6-month postpartumEPDS8169611.86- to 12-month postpartumEPDS684659.5Takehara 2018 \[[@CR145]\]1- to 3-month postpartumEPDS13051158.8Tamaki 1997 \[[@CR149]\]1-month postpartumEPDS62711418.20- to 1-month postpartumEPDS62711418.21- to 3-month postpartumEPDS6277612.1Tamaki 1997 \[[@CR148]\]3- to 6-month postpartumEPDS247629211.8Tamaki 2007 \[[@CR146]\]3- to 6-month postpartumEPDS3296118.5Tamaki 2008 \[[@CR147]\]1-month postpartumEPDS3616618.30- to 1-month postpartumEPDS3616618.3Tomari 2012 \[[@CR150]\]0- to 1-month postpartumEPDS3665314.5Tomimori 2011 \[[@CR151]\]1-month postpartumEPDS2714315.90- to 1-month postpartumEPDS1983216.2Umezaki 2015 \[[@CR152]\]1-month postpartumEPDS1143631.60- to 1-month postpartumEPDS1143833.3Urayama 2013 \[[@CR153]\]1-month postpartumEPDS1011817.80- to 1-month postpartumEPDS1013332.7Usuda 2016 \[[@CR154]\]1-month postpartumEPDS118119.30- to 1-month postpartumEPDS118119.3Usuda 2017 \[[@CR29]\]Second trimesterEPDS282141114.6Usui 2013 \[[@CR155]\]1-month postpartumCES-D1424128.90- to 1-month postpartumCES-D1424128.9Third trimesterCES-D1423927.5Yamaguchi 2016 \[[@CR156]\]1-month postpartumEPDS1011413.90- to 1-month postpartumEPDS1012019.81- to 3-month postpartumEPDS10198.93- to 6-month postpartumEPDS1011312.9Yamanaka 2012 \[[@CR157]\]1- to 3-month postpartumEPDS7868110.3Yamaoka 2016 \[[@CR158]\]3- to 6-month postpartumEPDS65346239.5Yamazaki 2016 \[[@CR161]\]0- to 1-month postpartumEPDS3636718.5Yamazaki 2017 \[[@CR160]\]0- to 1-month postpartumEPDS1053432.4Yamasaki 2017 \[[@CR159]\]3- to 6-month postpartumCES-D3994010.0Yoshida 2017 \[[@CR162]\]0- to 1-month postpartumEPDS2763813.8Table 2Major characteristics of studies: the effect of the childbirth experience on postpartum depressionAuthor, yearMeasurePrimiparasMultiparasSample sizeIdentified casesSample sizeIdentified casesAkiyama 2014 \[[@CR45]\]EPDS1942237107387Arai 2009 \[[@CR47]\]EPDS73217612Doi 2015 \[[@CR50]\]EPDS438507Fukuda 2011 \[[@CR55]\]EPDS1312816829Fukuzawa 2004 \[[@CR57]\]EPDS3835828114Fukuzawa 2006 \[[@CR58]\]EPDS1881816811Fukuzawa 2011 \[[@CR59]\]EPDS7311622Hamazaki 2009 \[[@CR61]\]EPDS4435654335Hozumi 2005 \[[@CR68]\]EPDS4913613Ichikawa 2008 \[[@CR69]\]EPDS68178412Ishii 2010 \[[@CR71]\]EPDS644452Kanai 2016 \[[@CR77]\]EPDS727411Kanazawa 2008 \[[@CR78]\]EPDS4266910Kikuchi 2007 \[[@CR82]\]EPDS1923423525Kishi 2009 \[[@CR86]\]EPDS8312778Kishimoto 2013 \[[@CR87]\]EPDS99141219Kobayashi 2017 \[[@CR10]\]EPDS59815536936Matsumoto 2011 \[[@CR92]\]EPDS3326234338Mishina 2010 \[[@CR96]\]EPDS164341159Mitamura 2008 \[[@CR98]\]EPDS2112031220Miyamoto 2012 \[[@CR101]\]EPDS7213566Mori 2016 \[[@CR103]\]EPDS18084301597161Muchanga 2017 \[[@CR9]\]EPDS24,340427657,3516907Nagatsuru 2006 \[[@CR108]\]EPDS1374211520Nakamura 2015 \[[@CR12]\]EPDS114121017Nakano 2004 \[[@CR110]\]EPDS7515859Ngoma 2012 \[[@CR111]\]EPDS415762Ninagawa 2005 \[[@CR112]\]EPDS1773015917Ono 2008 \[[@CR121]\]EPDS85236610Sato 2002 \[[@CR130]\]EPDS2154818736Satoh 2009 \[[@CR131]\]EPDS99297813Takehara 2018 \[[@CR145]\]EPDS72112258552Tamaki 1997a \[[@CR149]\]EPDS3537727336Tamaki 1997b \[[@CR148]\]EPDS10341471437144Tomari 2012 \[[@CR150]\]EPDS1363817715Urayama 2013 \[[@CR153]\]EPDS8230193Watanabe 2008 \[[@CR11]\]EPDS1111512415Yamaguchi 2016 \[[@CR156]\]EPDS4512568Yoshida 2017 \[[@CR162]\]EPDS1282314815

Prevalence of perinatal depression and subgroup analysis {#Sec9}
--------------------------------------------------------

The point prevalence of postpartum depression at 1 month after childbirth was calculated by integrating the 108,431 people from 63 publications and was found to be 14.3%. (95% CI 13.2--15.4%). The level of heterogeneity was *I*^2^ = 88.3%. Because of the high heterogeneity, the prevalence was calculated by a random-effects model (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Prevalence of postpartum depression 1 month after childbirth

A visual inspection of the funnel plot at 1 month after childbirth revealed symmetry (Fig. [3](#Fig3){ref-type="fig"}), and Egger's regression test for funnel plot asymmetry was statistically nonsignificant (*t* = 0.5958, *p* = 0.5535).Fig. 3Funnel plot at 1 month after childbirth

The period prevalence of depression at T1 could not be calculated due to a lack of reported data. The period prevalence of depression at T2 was 14.0% (95% CI 9.4--20.3%) based on the inclusion of 5271 people from 6 papers. Similarly, the period prevalence of depression was 16.3% at T3 (95% CI 12.2--21.5%), 15.1% at T4 (95% CI 14.2--16.1%), 11.6% at T5 (95% CI 9.2--14.5%), 11.5% at T6 (95% CI 10.4--12.7%) and 11.5% at T7 (95% CI 6.5--19.5%). From T2 to T7, high heterogeneity was observed in the prevalence data for all periods, so the prevalence was calculated by using a random-effects model (Fig. [4](#Fig4){ref-type="fig"}).Fig. 4Prevalence of perinatal depression as a function of the time period

Next, a subanalysis of the effect of the childbirth experience on postpartum depression was performed. The data for a total of 102,006 people described in 39 papers were integrated, and a meta-analysis was performed at the relative risk level. The result showed that primiparas had a significantly higher prevalence of postpartum depression than multiparas, with a relative risk of 1.76 (95% CI 1.59--1.96). The level of heterogeneity was *I*^2^ = 52.2%; the meta-analysis of relative risk was performed using a random-effects model (Fig. [5](#Fig5){ref-type="fig"}).Fig. 5Relative risk of the prevalence of postpartum depression between primiparas and multiparas

Trend analysis of the prevalence of perinatal depression {#Sec10}
--------------------------------------------------------

We performed a trend analysis by applying the generalized linear mixed model where outcome was existence of depression; link function was logit function; fixed effects were time (6 time points from T2 to T7; nominal variable) and scale (CES-D or EPDS); random effect was trial. As a result of the F test, there was no statistically significant difference between CES-D and EPDS in the prevalence of perinatal depression (*F* = 0.46, *p* = 0.501). The t tests on the contrast vectors for regression coefficients of the time variable were conducted in order to evaluate the difference between two time points in the prenatal period, and the trend of proportion in the postpartum period. The contrast vector for prenatal period was set as (− 1, 1, 0, 0, 0, 0), and postpartum period was set as (0, 0, 3, 1, − 1, − 3). The contrast vector for prenatal--postpartum comparison was set as (2, 2, − 1, − 1, − 1, − 1). As a result of trend analysis, a prevalence of prenatal depression increased statistically significantly over time (*t* = 3.78, *p* = 0.001), and a prevalence of postpartum depression decreased statistically significantly over time (*t* = 6.00, *p* \< 0.001). Comparing the prevalence of prenatal and postpartum depression, prevalence of prenatal depression was statistically significantly higher than that of postpartum depression (*t* = 4.11, *p* \< 0.001).

Sensitivity analysis of the prevalence of perinatal depression {#Sec11}
--------------------------------------------------------------

Additionally, a sensitivity analysis was performed to examine the robustness of the data. In particular, the analysis focused on heterogeneity. We found that when the study with the largest sample size (*n* = 82,489), i.e., the JECS \[[@CR9]\], was excluded, the prevalence of depression was 14.1% at 1 month postpartum (95% CI 12.8--15.5%, *I*^2^ = 88.1%, *n* = 25,942). There was no statistically significant difference in the prevalence of depression with or without the JECS data, and the heterogeneity was the same with or without JECS data.

The EPDS is the most frequently used measure to evaluate perinatal depression in women worldwide \[[@CR21]\], so we examined the prevalence of perinatal depression only with statistical data from the EPDS. The prevalence of perinatal depression after the sensitivity analysis is presented below.

The point prevalence of postpartum depression at 1 month after childbirth with the CES-D data excluded was 14.1%. (95% CI 13.1--15.2%). The level of heterogeneity was *I*^2^ = 88.0%.

The period prevalence of depression at T1 could not be calculated due to a lack of reported data. The period prevalence of depression at T2 was 11.8% (95% CI 8.6--15.9%). Similarly, the period prevalence of depression was 14.9% at T3 (95% CI 11.1--20.0%), 15.0% at T4 (95% CI 14.1--15.9%), 11.0% at T5 (95% CI 8.8--13.7%), 11.8% at T6 (95% CI 10.6--13.1%), and 10.8% at T7 (95% CI 5.5--20.1%). There was little statistical influence of the CES-D data on the robustness of the data.

Discussion {#Sec12}
==========

Our study is the first to use a meta-analysis to investigate the reliable prevalence of perinatal depression among Japanese women. The most important finding is that the point prevalence of postpartum depression was 14.3% 1 month after childbirth. The JECS \[[@CR9]\] is a large-scale study compared with other studies, so we tried to reanalyze the data with the JECS data excluded. The prevalence of postpartum depression and heterogeneity 1 month after childbirth were almost the same with or without the JECS data. While the JECS already identified the reliable prevalence of postpartum depression, our research confirms the extent of the heterogeneity in postpartum depression among Japanese women.

According to the DSM-IV-TR \[[@CR22]\], maternity blues are defined as depressive episodes that develop by the fifth day after childbirth and then disappear within 2 weeks. It is recommended that maternity blues and postpartum depression be clearly distinguished \[[@CR22]\]. Thus, it might be important to establish a sampling time to investigate the condition of postpartum depression 1 month after childbirth to exclude the possibility of maternity blues.

In Japan, the rate of infant health checkups 1 month after childbirth is high at 83.6% \[[@CR23]\], and infants' mothers are also checked for health problems at that time. Since Okano created the Japanese version of the EPDS \[[@CR16]\], this screening tool has been used for the early detection of a high risk of depression in mothers. Epidemiological studies of perinatal depression are mainly conducted by public health nurses and midwives in Japan. Although they often report research results in Japanese, sampling bias is less likely in these studies.

In addition, every year, approximately 100 women commit suicide in Japan because of worry about childcare, and the number has remained high \[[@CR24]\]. Recently, Takeda analyzed the abnormal deaths of perinatal women in Tokyo from 2005 to 2014 and reported that 63 suicides occurred during this period (23 cases during pregnancy and 40 cases under 1 year postpartum) \[[@CR25]\]. These women were suffering from mental illnesses, such as depression, and this figure was more than double the maternal mortality rate due to obstetric abnormalities. Therefore, it is important to estimate the prevalence of postpartum depression in Japan. In addition, postpartum depression may lead to child abuse \[[@CR26]\]. Therefore, to protect the health of children, more substantial measures against perinatal depression are needed.

Furthermore, the prevalence of postpartum depression in primiparas is higher than that in multiparas. This is a fundamentally important finding that has major implications for the national health care plan in Japan. There may be several reasons for this result. First, multiparas are expected to have some experience adapting to the stress of childbirth and childcare through the pregnancy experience. Second, a woman with a history of postpartum depression is known to have a high risk of depression during the birth of her second child \[[@CR27]\]. For this reason, a high-risk multipara has already received psychological education for perinatal depression and may take preventive measures. Third, if a woman suffered from perinatal depression in her first childbirth and did not receive adequate care, her motivation to give birth to a second child may be reduced. Further research is needed to provide details on the relationship between postpartum depression and family planning.

According to the DSM-5 \[[@CR28]\], 50% of cases of postpartum depression are known to have developed during pregnancy. Therefore, mood disorders not only postpartum, but also during pregnancy have also been attracting attention. Interestingly, the prevalence of depression increases as childbirth approaches during pregnancy and the prevalence decreases over time in the postpartum period. In particular, the prevalence of depression was the highest in the third trimester of pregnancy; however, a previous report suggested using different cutoff values for the EPDS for the periods before and after pregnancy \[[@CR29]\]. A similar trend has been observed in the United States, and large-scale cohort studies have reported that the prevalence of perinatal depression reaches its peak just before childbirth \[[@CR30]\]. During pregnancy, the prevalence of depression increases as childbirth approaches.

Sleep disorders, such as restless leg syndrome and frequent awakening at night, are known to occur most often in the third trimester of pregnancy \[[@CR31], [@CR32]\]. On the other hand, sleep quality improves over time after childbirth \[[@CR33]\]. In addition, urinary incontinence may also raise the risk of perinatal depression \[[@CR34]\]. During pregnancy, frequent urination is common \[[@CR35]\], and the degree of urinary incontinence is reported to increase as childbirth approaches \[[@CR36]\]. The worsening of frequent urination may affect the prevalence of depression during pregnancy. These studies attributed the increase in prevalence to organic problems of an epidemiological nature, but it is not possible to claim direct causal links between depression and biological factors.

The cessation of the use of antidepressants during pregnancy may also affect the increase in maternal depression prevalence. Pearlstein reported that although antidepressants are the most common treatment for postpartum depression, women tend to prefer psychotherapy \[[@CR37]\]. Certainly, there is strong evidence for the effectiveness of structured psychotherapy, such as cognitive behavioral therapy (CBT) \[[@CR38]\], interpersonal psychotherapy (IPT) \[[@CR39]\] and psychological education \[[@CR30], [@CR40]\], for treating and preventing perinatal depression. Therefore, psychotherapy should be considered the first choice, depending on the patient's condition. However, the need for drug therapy should also be considered. Suzuki reported that depression declined in Japanese women who had been treated for depression after they had stopped antidepressants after pregnancy \[[@CR41]\]. The JECS also showed that Japanese women tend to refrain from taking drugs when pregnant. These women again increase their rate of medication after birth \[[@CR42]\]. Interestingly, the incidence of postpartum depression is reported to be very low among women with no history of mental illness \[[@CR27]\]. In other words, patients with postpartum depression may have had a predisposition for depression before onset. It was also reported that women who discontinued antidepressant medication experienced a relapse of major depression during pregnancy significantly more frequently than women who maintained their medication (hazard ratio, 5.0; 95% confidence interval, 2.8--9.1; *p* \< 0.001) \[[@CR43]\]. Therefore, drug treatment strategies should be carefully assessed by a psychiatrist with a case-by-case approach when pharmacotherapy is administered to perinatal women.

Limitations {#Sec13}
===========

This study has several limitations. First, the prevalence of depression in the perinatal period was reported based on screening test results. This approach may have resulted in the inclusion of people who should not be clinically diagnosed with depression, such as people with bipolar affective disorder. We included studies that used the CES-D and EPDS as tools to evaluate depression. Although other depression screening methods, such as the 2-item method, the Self-Rating Depression Scale (SDS), the Research Diagnostic Criteria (RDC) and the Mini International Neuropsychiatric Interview (MINI), have been reported, the EPDS and CES-D are the major tools for evaluating a depressed state during the perinatal period according to a prior study \[[@CR44]\]. Because group heterogeneity increases when another evaluation scale is added, we limited our analysis to those two tools. Second, a recent report suggested that the cutoff should be 12 rather than 9 points when using the Japanese version of the EPDS to screen for depression during pregnancy \[[@CR29]\]. It is possible that the prenatal and postpartum scores should not be assessed in the same way. Third, an internal bias may have been present, because our meta-analysis included only Japanese patients.

Conclusion {#Sec14}
==========

Our meta-analysis provided reliable estimates of the prevalence of perinatal depression among Japanese women. The point prevalence of postpartum depression 1 month after childbirth was found to be 14.3%, and the data had high heterogeneity. Our results indicated that during pregnancy, the prevalence of depression increased as childbirth approached, and the prevalence decreases over time in the postpartum period. In addition, we found that the prevalence of postpartum depression in primiparas was higher than that in multiparas. Hence, we suggest that healthcare professionals need to pay more attention to primiparas than multiparas regarding postpartum depression.
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